These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 523359)

  • 21. [Basis of antifungal chemotherapy].
    Arai T; Uno H
    Nihon Saikingaku Zasshi; 1983; 38(2):525-48. PubMed ID: 6350637
    [No Abstract]   [Full Text] [Related]  

  • 22. [New aspects in treatment of systemic mycoses].
    Presterl E; Graninger W
    Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation.
    Pancham S; Hemmaway C; New H; Albert E; Dokal I; Roberts IA; McCloy M
    Pediatr Transplant; 2005 Apr; 9(2):254-7. PubMed ID: 15787803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone.
    Zaremba M; Borowski J; Feliński J; Rozkiewicz D; Rozkiewicz M; Zaremba K; Czerwiński A; Borowski E
    J Chemother; 1989 Jul; 1(4 Suppl):243-5. PubMed ID: 16312386
    [No Abstract]   [Full Text] [Related]  

  • 25. The multitude of targets for the immune system and drug therapy in the fungal cell wall.
    Nimrichter L; Rodrigues ML; Rodrigues EG; Travassos LR
    Microbes Infect; 2005 Apr; 7(4):789-98. PubMed ID: 15823515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal agents useful in therapy of systemic fungal infections.
    Medoff G; Brajtburg J; Kobayashi GS; Bolard J
    Annu Rev Pharmacol Toxicol; 1983; 23():303-30. PubMed ID: 6307124
    [No Abstract]   [Full Text] [Related]  

  • 27. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
    Groll AH; Walsh TJ
    Mycoses; 2006; 49 Suppl 1():7-16. PubMed ID: 16961576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human mycoses: drugs and targets for emerging pathogens.
    Georgopapadakou NH; Walsh TJ
    Science; 1994 Apr; 264(5157):371-3. PubMed ID: 8153622
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.
    Sionov E; Mendlovic S; Segal E
    J Infect; 2006 Aug; 53(2):131-9. PubMed ID: 16360214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing the challenges of invasive fungal infections.
    Herbrecht R
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():1-2. PubMed ID: 16701981
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New challenges to the therapy of systemic fungal infections.
    Medoff G
    Trans Am Clin Climatol Assoc; 1996; 107():146-57; discussion 157-8. PubMed ID: 8725568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Refractory respiratory tract infections. 9. Chemotherapy of recent respiratory tract infections. d. Mycoses].
    Mori T; Takahashi M; Ikemoto H
    Nihon Rinsho; 1987 Mar; 45(3):627-31. PubMed ID: 3298740
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanisms of resistance to antifungal agents].
    Makimura K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():466-70. PubMed ID: 17455664
    [No Abstract]   [Full Text] [Related]  

  • 35. [Management of visceral mycoses, with special reference to drug therapy].
    Ikemoto H
    Nihon Rinsho; 1980 Nov; 38(11):4386-92. PubMed ID: 7253229
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy of mycoses of the inner organs].
    Scholer HJ
    Schweiz Med Wochenschr; 1968 Apr; 98(16):602-11. PubMed ID: 5688589
    [No Abstract]   [Full Text] [Related]  

  • 37. AmBisome targeting to fungal infections.
    Adler-Moore J
    Bone Marrow Transplant; 1994; 14 Suppl 5():S3-7. PubMed ID: 7703928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
    Maschmeyer G; Glasmacher A
    Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs.
    Borelli D; Bran JL; Fuentes J; Legendre R; Leiderman E; Levine HB; Restrepo A; Stevens DA
    Postgrad Med J; 1979 Sep; 55(647):657-61. PubMed ID: 523356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
    Lyman CA; Walsh TJ
    Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.